阿利克仑
|
A125767-50mg
|
Moligand™, ≥98% |
173334-57-1 |
50mg
|
¥ 952.9
|
现货 |
阿拉丁 |
阿利克仑
|
A125767-10mg
|
Moligand™, ≥98% |
173334-57-1 |
10mg
|
¥ 304.9
|
现货 |
阿拉丁 |
安帕莱克斯
|
A125747-500mg
|
Moligand™, ≥95% |
154235-83-3 |
500mg
|
¥ 1798.9
|
现货 |
阿拉丁 |
安帕莱克斯
|
A125747-100mg
|
Moligand™, ≥95% |
154235-83-3 |
100mg
|
¥ 421.9
|
现货 |
阿拉丁 |
阿比特龙
|
A125745-100mg
|
Moligand™, ≥99% |
154229-19-3 |
100mg
|
¥ 1297.9
|
现货 |
阿拉丁 |
阿比特龙
|
A125745-25mg
|
Moligand™, ≥99% |
154229-19-3 |
25mg
|
¥ 452.9
|
现货 |
阿拉丁 |
阿比特龙
|
A125745-5mg
|
Moligand™, ≥99% |
154229-19-3 |
5mg
|
¥ 388.9
|
现货 |
阿拉丁 |
ABT-751 (E7010),抗有丝分裂剂
|
A125698-100mg
|
≥98% |
141430-65-1 |
100mg
|
¥ 962.9
|
现货 |
阿拉丁 |
ABT-751 (E7010),抗有丝分裂剂
|
A125698-50mg
|
≥98% |
141430-65-1 |
50mg
|
¥ 632.9
|
现货 |
阿拉丁 |
ABT-751 (E7010),抗有丝分裂剂
|
A125698-10mg
|
≥98% |
141430-65-1 |
10mg
|
¥ 366.9
|
现货 |
阿拉丁 |
N-[4-(4-氨基-1-哌啶基)-2-甲氧基苯基]-5-氯-4-(1H-吲哚-3-基)-2-嘧啶胺
|
A125664-100mg
|
Moligand™, ≥98% |
1356962-20-3 |
100mg
|
¥ 4220.9
|
现货 |
阿拉丁 |
N-[4-(4-氨基-1-哌啶基)-2-甲氧基苯基]-5-氯-4-(1H-吲哚-3-基)-2-嘧啶胺
|
A125664-25mg
|
Moligand™, ≥98% |
1356962-20-3 |
25mg
|
¥ 1361.9
|
现货 |
阿拉丁 |
N-[4-(4-氨基-1-哌啶基)-2-甲氧基苯基]-5-氯-4-(1H-吲哚-3-基)-2-嘧啶胺
|
A125664-5mg
|
Moligand™, ≥98% |
1356962-20-3 |
5mg
|
¥ 401.9
|
现货 |
阿拉丁 |
AZ20,ATR抑制剂
|
A125603-50mg
|
Moligand™, ≥98% |
1233339-22-4 |
50mg
|
¥ 2899.9
|
现货 |
阿拉丁 |
AZ20,ATR抑制剂
|
A125603-10mg
|
Moligand™, ≥98% |
1233339-22-4 |
10mg
|
¥ 790.9
|
现货 |
阿拉丁 |
AZ20,ATR抑制剂
|
A125603-5mg
|
Moligand™, ≥98% |
1233339-22-4 |
5mg
|
¥ 396.9
|
现货 |
阿拉丁 |
4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸
|
A125594-50mg
|
Moligand™, ≥98% |
1228690-19-4 |
50mg
|
¥ 4119.9
|
现货 |
阿拉丁 |
4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸
|
A125594-10mg
|
Moligand™, ≥98% |
1228690-19-4 |
10mg
|
¥ 897.9
|
现货 |
阿拉丁 |
4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸
|
A125594-5mg
|
Moligand™, ≥98% |
1228690-19-4 |
5mg
|
¥ 677.9
|
现货 |
阿拉丁 |
N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺
|
A125560-100mg
|
Moligand™, ≥99% |
558447-26-0 |
100mg
|
¥ 13410.9
|
期货,请咨询 |
阿拉丁 |
N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺
|
A125560-50mg
|
Moligand™, ≥99% |
558447-26-0 |
50mg
|
¥ 8142.9
|
期货,请咨询 |
阿拉丁 |
N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺
|
A125560-25mg
|
Moligand™, ≥99% |
558447-26-0 |
25mg
|
¥ 4523.9
|
期货,请咨询 |
阿拉丁 |
N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺
|
A125560-10mg
|
Moligand™, ≥99% |
558447-26-0 |
10mg
|
¥ 2102.9
|
期货,请咨询 |
阿拉丁 |
N'-(1H-苯并咪唑-2-甲基)-N'-((S)-5,6,7,8-四氢喹啉-8-基)丁烷-1,4-二胺
|
A125560-5mg
|
Moligand™, ≥99% |
558447-26-0 |
5mg
|
¥ 1341.9
|
期货,请咨询 |
阿拉丁 |